Karyopharm Therapeutics Stock Forecast - Day Median Price
| KPTI Stock | USD 1.08 0.05 4.85% |
Karyopharm Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Karyopharm Therapeutics stock prices and determine the direction of Karyopharm Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Karyopharm Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Karyopharm Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Karyopharm Therapeutics' systematic risk associated with finding meaningful patterns of Karyopharm Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Karyopharm Therapeutics to cross-verify your projections. Karyopharm |
Open Interest Against 2024-05-17 Karyopharm Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Karyopharm Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Karyopharm Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Karyopharm Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Karyopharm Therapeutics' open interest, investors have to compare it to Karyopharm Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Karyopharm Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Karyopharm. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Karyopharm Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Karyopharm Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Karyopharm Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Median Price is the statistical median of an asset price for a given trading period.| Previous Day Median Price | Day Median Price | Trend |
| 4.5 | 4.43 |
| Check Karyopharm Therapeutics Volatility | Backtest Karyopharm Therapeutics | Trend Details |
Karyopharm Therapeutics Trading Date Momentum
| On July 29 2022 Karyopharm Therapeutics was traded for 4.25 at the closing time. The top price for the day was 4.41 and the lowest listed price was 4.13 . The trading volume for the day was 2.5 M. The trading history from July 29, 2022 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.71% . The trading delta at closing time against the current closing price is 10.31% . |
The median price is the midpoint of the trading periods range.
| Compare Karyopharm Therapeutics to competition |
Other Forecasting Options for Karyopharm Therapeutics
For every potential investor in Karyopharm, whether a beginner or expert, Karyopharm Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Karyopharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Karyopharm. Basic forecasting techniques help filter out the noise by identifying Karyopharm Therapeutics' price trends.Karyopharm Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Karyopharm Therapeutics stock to make a market-neutral strategy. Peer analysis of Karyopharm Therapeutics could also be used in its relative valuation, which is a method of valuing Karyopharm Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Karyopharm Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Karyopharm Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Karyopharm Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Karyopharm Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Karyopharm Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Karyopharm Therapeutics shares will generate the highest return on investment. By undertsting and applying Karyopharm Therapeutics stock market strength indicators, traders can identify Karyopharm Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 69027.68 | |||
| Daily Balance Of Power | 0.625 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 1.09 | |||
| Day Typical Price | 1.09 | |||
| Price Action Indicator | 0.015 | |||
| Period Momentum Indicator | 0.05 |
Karyopharm Therapeutics Risk Indicators
The analysis of Karyopharm Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Karyopharm Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting karyopharm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.39 | |||
| Semi Deviation | 5.81 | |||
| Standard Deviation | 8.74 | |||
| Variance | 76.42 | |||
| Downside Variance | 41.74 | |||
| Semi Variance | 33.74 | |||
| Expected Short fall | (9.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Karyopharm Therapeutics to cross-verify your projections. For more detail on how to invest in Karyopharm Stock please use our How to Invest in Karyopharm Therapeutics guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Karyopharm Stock analysis
When running Karyopharm Therapeutics' price analysis, check to measure Karyopharm Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karyopharm Therapeutics is operating at the current time. Most of Karyopharm Therapeutics' value examination focuses on studying past and present price action to predict the probability of Karyopharm Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karyopharm Therapeutics' price. Additionally, you may evaluate how the addition of Karyopharm Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Karyopharm Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Karyopharm Therapeutics. If investors know Karyopharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Karyopharm Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.25) | Revenue Per Share 1.279 | Quarterly Revenue Growth 0.005 | Return On Assets (0.27) | Return On Equity (8.91) |
The market value of Karyopharm Therapeutics is measured differently than its book value, which is the value of Karyopharm that is recorded on the company's balance sheet. Investors also form their own opinion of Karyopharm Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Karyopharm Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Karyopharm Therapeutics' market value can be influenced by many factors that don't directly affect Karyopharm Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Karyopharm Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Karyopharm Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Karyopharm Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.